Sign in
4

Changes in Ownership

Elicio Therapeutics, Inc. Filed Acc 0001140361-24-005496

Options or other derivatives

  • Chief Scientific Officer acquired 30,142 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DeMuth Peter · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-01 Grant or award : show line 1 in the form Stock Option (right to buy) +29,800 29,800 D
2024-02-01 Grant or award : show line 2 in the form Stock Option (right to buy) +342 342 D
Loading xslF345X05/form4.xml…